Risedronate and ascites Patient Reports February 12, 2012

Risedronate Side Effects Report #4629412-8
Risedronate side effect was reported by a Physician from on Mar 24, 2005. Female patient, 70 years of age, was diagnosed with spinal compression fracture and was treated with Risedronate. After drug was administered, patient experienced the following side effects: ascites, blood lactate dehydrogenase increased, cholelithiasis, colitis, colitis ulcerative, colonic stenosis, coxsackie viral infection, coxsackie virus serology test positive, erythema. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with ELCITONIN, VOLTAREN, ASPARA, AMOBAN, PURSENNID. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #5066135-8
Risedronate side effect was reported by a Physician from JAPAN on July 11, 2006. Female patient, 58 years of age, was diagnosed with osteoporosis prophylaxis and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alpha 1 foetoprotein increased, ascites, bile duct cancer, blood albumin decreased, carbohydrate antigen 19-9 increased, carcinoembryonic antigen increased, cholangitis sclerosing, haemorrhage, hepatic failure. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with HORMONES AND RELATED AGENTS, PREDNISOLONE, PENTASA, NEO MINOPHAGEN C, URSO, PREDONINE. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #5043236-1
Risedronate side effect was reported by a Physician from JAPAN on June 12, 2006. Female patient, 69 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: agitation, alanine aminotransferase increased, aortic calcification, ascites, aspartate aminotransferase increased, base excess, bladder disorder, blood calcium decreased, blood cholesterol increased. Risedronate dosage: 2.5 MG, DAILY, ORAL. During the same period patient was treated with ZOLPIDEM TARTRATE, DEPAS, DICLOFENAC. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #5926100-2
Risedronate side effect was reported by a Physician from JAPAN on Oct 06, 2008. Male patient, 89 years of age, was diagnosed with fracture , osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: ascites, blood cholesterol increased, blood triglycerides increased, hypoalbuminaemia, nephrotic syndrome, pleural effusion. Risedronate dosage: 17.5 MG ONCE WEEKLY, ORAL. During the same period patient was treated with BUFFERIN, NEUROVITAN, THYRADIN. Patient was hospitalized. Patient recovered.